NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
16.48
-0.30 (-1.79%)
Dec 11, 2025, 4:00 PM EST - Market closed
NeuroPace Employees
NeuroPace had 184 employees as of December 31, 2024. The number of employees increased by 13 or 7.60% compared to the previous year.
Employees
184
Change (1Y)
13
Growth (1Y)
7.60%
Revenue / Employee
$515,565
Profits / Employee
-$130,359
Market Cap
548.91M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 184 | 13 | 7.60% |
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NPCE News
- 3 days ago - NeuroPace Announces Positive 18-Month NAUTILUS Trial Results in Idiopathic Generalized Epilepsy - Business Wire
- 9 days ago - NeuroPace to Highlight Life-Changing Outcomes and AI-Powered Confident Care at the 2025 American Epilepsy Society (AES) Annual Meeting - Business Wire
- 17 days ago - NeuroPace Announces Favorable Medicare Reimbursement Increases for RNS System Physician and Hospital Outpatient Services - Business Wire
- 5 weeks ago - NeuroPace, Inc. (NPCE) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - NeuroPace Reports Third Quarter 2025 Financial Results and Increases 2025 Revenue Guidance - Business Wire
- 7 weeks ago - NeuroPace to Report Third Quarter 2025 Financial Results on November 4, 2025 - Business Wire
- 3 months ago - NeuroPace to Participate in Upcoming Healthcare Conferences - Business Wire
- 4 months ago - NeuroPace, Inc. (NPCE) Q2 2025 Earnings Call Transcript - Seeking Alpha